COVID-19 vaccines adverse events: potential molecular mechanisms
M Lamprinou, A Sachinidis, E Stamoula, T Vavilis… - Immunologic …, 2023 - Springer
COVID-19 is an infectious disease caused by a single-stranded RNA (ssRNA) virus, known
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …
as SARS-CoV-2. The disease, since its first outbreak in Wuhan, China, in December 2019 …
COVID-19: Insights into potential vaccines
People around the world ushered in the new year 2021 with a fear of COVID-19, as family
members have lost their loved ones to the disease. Millions of people have been infected …
members have lost their loved ones to the disease. Millions of people have been infected …
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
Immunization programs against SARS-CoV-2 with commercial intramuscular vaccines
prevent disease but are less efficient in preventing infections. Mucosal vaccines can provide …
prevent disease but are less efficient in preventing infections. Mucosal vaccines can provide …
Sharia (Islamic Law) Perspectives of COVID-19 Vaccines
Y Mardian, K Shaw-Shaliba, M Karyana… - Frontiers in Tropical …, 2021 - frontiersin.org
The Coronavirus disease 2019 (COVID-19) pandemic has caused health, economic, and
social challenges globally. Under these circumstances, effective vaccines play a critical role …
social challenges globally. Under these circumstances, effective vaccines play a critical role …
Repurposing ivermectin for COVID-19: Molecular aspects and therapeutic possibilities
As of January 2021, SARS-CoV-2 has killed over 2 million individuals across the world. As
such, there is an urgent need for vaccines and therapeutics to reduce the burden of COVID …
such, there is an urgent need for vaccines and therapeutics to reduce the burden of COVID …
Reinfections in COVID-19 patients: impact of virus genetic variability and host immunity
A Fakhroo, HA AlKhatib, AA Al Thani, HM Yassine - Vaccines, 2021 - mdpi.com
The COVID-19 pandemic is still posing a devastating threat to social life and economics.
Despite the modest decrease in the number of cases during September–November 2020 …
Despite the modest decrease in the number of cases during September–November 2020 …
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
G Abdolmaleki, MA Taheri, S Paridehpour… - DARU Journal of …, 2022 - Springer
Since the outbreak of the novel coronavirus disease 2019 (COVID-19) in Wuhan, China,
many health care systems have been heavily engaged in treating and preventing the …
many health care systems have been heavily engaged in treating and preventing the …
[HTML][HTML] SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
Non-pharmacological interventions and tracing-testing strategy proved insufficient to reduce
SARS-CoV-2 spreading worldwide. Several vaccines with different mechanisms of action …
SARS-CoV-2 spreading worldwide. Several vaccines with different mechanisms of action …
The race for COVID-19 vaccines: the various types and their strengths and weaknesses
BK Muhar, J Nehira, A Malhotra… - Journal of Pharmacy …, 2023 - journals.sagepub.com
SARS-CoV-2 causes the highly contagious coronavirus disease (COVID-19), first
discovered in Wuhan, China, in December of 2019. As of August 21, 2021, over 211 million …
discovered in Wuhan, China, in December of 2019. As of August 21, 2021, over 211 million …
[HTML][HTML] Roles of existing drug and drug targets for COVID-19 management
AG Ayele, EF Enyew, ZD Kifle - Metabolism Open, 2021 - Elsevier
In December 2019, a highly transmissible, pneumonia epidemic caused by a novel
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in …
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), erupted in …